Illinois Municipal Retirement Fund Has $622,000 Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Illinois Municipal Retirement Fund boosted its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 7.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 47,409 shares of the company’s stock after purchasing an additional 3,411 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in Pediatrix Medical Group were worth $622,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Quest Partners LLC raised its stake in Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after purchasing an additional 622 shares in the last quarter. Everence Capital Management Inc. raised its stake in Pediatrix Medical Group by 7.5% in the fourth quarter. Everence Capital Management Inc. now owns 13,840 shares of the company’s stock valued at $182,000 after purchasing an additional 960 shares in the last quarter. Quarry LP raised its stake in Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after purchasing an additional 1,662 shares in the last quarter. Atria Investments Inc raised its stake in Pediatrix Medical Group by 9.0% in the third quarter. Atria Investments Inc now owns 27,124 shares of the company’s stock valued at $314,000 after purchasing an additional 2,238 shares in the last quarter. Finally, Rhumbline Advisers raised its stake in Pediatrix Medical Group by 1.7% in the fourth quarter. Rhumbline Advisers now owns 224,701 shares of the company’s stock valued at $2,948,000 after purchasing an additional 3,822 shares in the last quarter. Institutional investors and hedge funds own 97.71% of the company’s stock.

Analyst Ratings Changes

MD has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft lifted their target price on Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Truist Financial lifted their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research report on Friday, February 21st. Jefferies Financial Group lifted their target price on Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Finally, Mizuho lifted their target price on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Tuesday, November 19th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $17.08.

Pediatrix Medical Group Stock Performance

NYSE:MD opened at $14.46 on Tuesday. The stock has a market cap of $1.24 billion, a P/E ratio of -12.05, a price-to-earnings-growth ratio of 1.74 and a beta of 1.57. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The stock’s 50-day moving average is $13.99 and its 200-day moving average is $13.19. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.12. The company had revenue of $502.36 million for the quarter, compared to analysts’ expectations of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. Equities research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.